SCOPUS 정보 검색 플랫폼

Archives of Internal Medicine

Volumn 148, Issue 4, 1988, Pages 785-787

National Adverse Drug Reaction Surveillance: 1986

(3) Faich, Gerald A a Dreis, Michael a Tomita, Dianne a

a CENTER FOR DRUG EVALUATION AND RESEARCH (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CARDIAC AGENT; HORMONE;

ADVERSE DRUG REACTION; DRUG SURVEILLANCE PROGRAM; EPIDEMIOLOGY; HUMAN;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DRUG THERAPY; EVALUATION STUDIES; FEMALE; HUMAN; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGE; PRODUCT SURVEILLANCE, POSTMARKETING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0023921219 PISSN: 00039926 EISSN: 15383679 Source Type: Journal
DOI: 10.1001/archinte.1988.00380040025005 Document Type: Article

Times cited : (34)

References (16)

1
- 0008579705
- Detection and prevention of drug-induced blood dyscrasias
- Ersler AJ, Wintrobe MM: Detection and prevention of drug-induced blood dyscrasias. JAMA 1962;181:114-119.
- (1962) JAMA , vol.181 , pp. 114-119
- Ersler, A.J.¹ Wintrobe, M.M.²

2
- 0003396336
- (ed) New York, Marcel Dekker Inc,
- Schardein JL (ed): Chemically Induced Birth Defects. New York, Marcel Dekker Inc, 1985, pp 215-259.
- (1985) Chemically Induced Birth Defects , pp. 215-259
- Schardein, J.L.¹

3
- 0023622741
- Clinical trials are not enough: Drug development and pharmacy epidemiology
- Faich GA, Lawson DH, Tilson HH, et al: Clinical trials are not enough: Drug development and pharmacy epidemiology. J Clin Res Drug Dev 1987;1:75-78.
- (1987) J Clin Res Drug Dev , vol.1 , pp. 75-78
- Faich, G.A.¹ Lawson, D.H.² Tilson, H.H.³

4
- 0018409824
- Postmarketing surveillance of new drugs: I. Review of objectives and methodology
- Wardell WM, Tsianco MC, Awavekar SN, et al: Postmarketing surveillance of new drugs: I. Review of objectives and methodology. J Clin Pharmacol 1979;19:85-94.
- (1979) J Clin Pharmacol , vol.19 , pp. 85-94
- Wardell, W.M.¹ Tsianco, M.C.² Awavekar, S.N.³

5
- 0022628247
- Adverse drug reaction monitoring
- Faich GA: Adverse drug reaction monitoring. N Engl J Med 1986;314:1584-1592.
- (1986) N Engl J Med , vol.314 , pp. 1584-1592
- Faich, G.A.¹

6
- 84942185896
- New drug and antibiotic regulations; final rule; section 314.80. Post-marketing reporting of adverse drug experiences
- Feb 22
- New drug and antibiotic regulations; final rule; section 314.80. Post-marketing reporting of adverse drug experiences. Federal Register 1985;50(Feb 22):7500-7504.
- (1985) Federal Register , vol.50 , pp. 7500-7504

7
- 84874612988
- The processing of adverse reaction reports at FDA
- Turner WM, Milstein JB, Faich GA, et al: The processing of adverse reaction reports at FDA. Drug Informat J 1986;20:147-150.
- (1986) Drug Informat J , vol.20 , pp. 147-150
- Turner, W.M.¹ Milstein, J.B.² Faich, G.A.³

8
- 0023142644
- Ulcerogenicity of piroxicam
- Rossi AC, Hsu JP, Faich GA: Ulcerogenicity of piroxicam. Br Med J 1987;294:147-150.
- (1987) Br Med J , vol.294 , pp. 147-150
- Rossi, A.C.¹ Hsu, J.P.² Faich, G.A.³

9
- 0023145893
- National adverse drug reaction surveillance: 1985
- Faich GA, Knapp D, Dreis M, et al: National adverse drug reaction surveillance: 1985. JAMA 1986;257:2068-2070.
- (1986) JAMA , vol.257 , pp. 2068-2070
- Faich, G.A.¹ Knapp, D.² Dreis, M.³

10
- 0016194241
- Hospitalizations due to drug reactions
- Miller RR, Jick H: Hospitalizations due to drug reactions. Arch Intern Med 1974;134:219-223.
- (1974) Arch Intern Med , vol.134 , pp. 219-223
- Miller, R.R.¹ Jick, H.²

11
- 0019423597
- Drug-related problems causing admission to a medical clinic
- Bergman U, Wiholm BE: Drug-related problems causing admission to a medical clinic. Eur J Clin Pharm 1981;20:193-200.
- (1981) Eur J Clin Pharm , vol.20 , pp. 193-200
- Bergman, U.¹ Wiholm, B.E.²

12
- 0022416003
- Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy
- Brown P, Gajdusek DC, Gibbs CJ, et al: Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 1985;312:728-730.
- (1985) N Engl J Med , vol.312 , pp. 728-730
- Brown, P.¹ Gajdusek, D.C.² Gibbs, C.J.³

13
- 0022816151
- Suprofen labeling revised
- Suprofen labeling revised. FDA Drug Bull 1986;16:15-16.
- (1986) FDA Drug Bull , vol.16 , pp. 15-16

14
- 0022418459
- Fansidar: Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria
- Fansidar: Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria. MMWR 1984;33:713-714.
- (1984) MMWR , vol.33 , pp. 713-714

15
- 84942188582
- Nomifensine
- Nomifensine. FDA Drug Bull 1986;16:7-8.
- (1986) FDA Drug Bull , vol.16 , pp. 7-8

16
- 0021951775
- Better reporting of adverse drug reactions
- Abrutyn E: Better reporting of adverse drug reactions. Ann Intern Med 1985;102:264-265.
- (1985) Ann Intern Med , vol.102 , pp. 264-265
- Abrutyn, E.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.